ARCHIVES

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

This article is from The Cancer Letter archive.

Vol. 34 No. 29 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Lung cancer screening trial reaches accrual goal of 50,000.

January 30, 2004

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990